Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson L Michael

Showing results (141-150 of 387) with videos related to

Pageof 39
Sort By:
Plos One|September 28, 2011
A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cellsMichael A Eller, Bonnie M Slike, Josephine H Cox, et al.
Immunogenetics|April 1, 2014
HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trialHeather A Prentice, Philip K Ehrenberg, Karen M Baldwin, et al.
The Journal of Infectious Diseases|August 31, 2018
Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected KenyansAndrew Letizia, Michael A Eller, Christina Polyak, et al.
Journal of Clinical Microbiology|August 28, 2015
Evaluation of Performance of Two Rapid Tests for Detection of HIV-1 and -2 in High- and Low-Prevalence Populations in NigeriaMark M Manak, Ogbonnaya S Njoku, Ashley Shutt, et al.
Military Medicine|June 1, 2012
Enhanced U.S. Army HIV diagnostic algorithm used to diagnose acute HIV infection in a deployed soldierShilpa Hakre, Robert M Paris, Julie E Brian, et al.
The Journal of Infectious Diseases|October 7, 2010
Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, TanzaniaRebecca N Koehler, Anne M Walsh, Elmar Saathoff, et al.
Journal of Virus Eradication|February 3, 2016
Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensificationJintanat Ananworanich, Nicolas Chomont, James Lk Fletcher, et al.
AIDS Research and Human Retroviruses|May 17, 2012
Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donorsWiriya Rutvisuttinunt, Sunee Sirivichayakul, Sineenart Oota, et al.
Scientific Reports|April 23, 2017
A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infectionYufei Wang, Trevor Whittall, Stuart Neil, et al.
Virology|March 28, 2008
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccinationVictoria R Polonis, Bruce K Brown, Andrew Rosa Borges, et al.
Pageof 39

Showing results (141-150 of 387) with videos related to

Sort By:
Pageof 39
Plos One|September 28, 2011
A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cellsMichael A Eller, Bonnie M Slike, Josephine H Cox, et al.
Immunogenetics|April 1, 2014
HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trialHeather A Prentice, Philip K Ehrenberg, Karen M Baldwin, et al.
The Journal of Infectious Diseases|August 31, 2018
Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected KenyansAndrew Letizia, Michael A Eller, Christina Polyak, et al.
Journal of Clinical Microbiology|August 28, 2015
Evaluation of Performance of Two Rapid Tests for Detection of HIV-1 and -2 in High- and Low-Prevalence Populations in NigeriaMark M Manak, Ogbonnaya S Njoku, Ashley Shutt, et al.
Military Medicine|June 1, 2012
Enhanced U.S. Army HIV diagnostic algorithm used to diagnose acute HIV infection in a deployed soldierShilpa Hakre, Robert M Paris, Julie E Brian, et al.
The Journal of Infectious Diseases|October 7, 2010
Class I HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, TanzaniaRebecca N Koehler, Anne M Walsh, Elmar Saathoff, et al.
Journal of Virus Eradication|February 3, 2016
Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensificationJintanat Ananworanich, Nicolas Chomont, James Lk Fletcher, et al.
AIDS Research and Human Retroviruses|May 17, 2012
Two unique recombinant forms identified in incident HIV type 1 infections in Thai blood donorsWiriya Rutvisuttinunt, Sunee Sirivichayakul, Sineenart Oota, et al.
Scientific Reports|April 23, 2017
A novel mechanism linking memory stem cells with innate immunity in protection against HIV-1 infectionYufei Wang, Trevor Whittall, Stuart Neil, et al.
Virology|March 28, 2008
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccinationVictoria R Polonis, Bruce K Brown, Andrew Rosa Borges, et al.
Pageof 39